1.3M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Charles Newton | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 17 Mar 2025 | 200,000 | 200,000 | - | 0.6 | 111,620 | Common Stock |
| Richard D. Klausner | Director | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 14 Mar 2025 | 158,000 | 843,365 | - | 0.6 | 94,942 | Common Stock |
| Lynn Seely | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.61 per share. | 14 Mar 2025 | 175,000 | 712,500 | - | 0.6 | 106,190 | Common Stock |
| Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 337,500 | 537,500 | - | 0 | Common Stock | |
| Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 176,696 | - | 0 | Common Stock | |
| Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 172,899 | - | 0 | Common Stock | |
| Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Newton Charles | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 172,725 | - | 0 | Common Stock | |
| Lynn Seely | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 1,350,000 | 1,350,000 | - | - | Option (right to buy) | |
| Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 168,750 | 168,750 | - | - | Option (right to buy) | |
| Lang Matthew | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 162,500 | - | 0 | Common Stock | |
| Sumant Ramachandra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 260,000 | 260,000 | - | - | Option (right to buy) | |
| Catherine J. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| William J. Rieflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Richard D. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Elizabeth G. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
| Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 48,928 | - | 0 | Common Stock | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 48,729 | - | 0 | Common Stock | |
| Matthew Lang | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 500,000 | 500,000 | - | - | Option (right to buy) | |
| Matthew Lang | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 52,700 | - | 0 | Common Stock | |
| Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | 0 | Common Stock | |
| Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Richard D. Klausner | Director | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 15 Aug 2023 | 58,020 | 930,880 | - | 2.3 | 132,286 | Common Stock |
| Elizabeth G. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Richard D. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| William J. Rieflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Catherine J. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Tina Albertson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 700,000 | 700,000 | - | - | Option (right to buy) | |
| Stephen Hill | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 900,000 | 900,000 | - | - | Option (right to buy) | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 700,000 | 700,000 | - | - | Option (right to buy) | |
| Rahsaan Thompson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 245,000 | 245,000 | - | - | Option (right to buy) | |
| Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 600,000 | 600,000 | - | - | Option (right to buy) | |
| Lynn Seely | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 7,500,000 | 7,500,000 | - | - | Option (right to buy) | |
| Rahsaan Thompson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 715,000 | 715,000 | - | - | Option (right to buy) | |
| Richard D. Klausner | Director | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 23 Sep 2022 | 11,100 | 988,900 | - | 6.4 | 71,041 | Common Stock |
| Hans Edgar Bishop | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share. | 08 Sep 2022 | 145,380 | 4,685,614 | - | 0.1 | 14,538 | Common Stock |
| Hans Edgar Bishop | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 145,380 | 24,230 | - | - | Option (right to buy) | |
| Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Elizabeth G. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| William J. Rieflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lynn Seely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Robert Taylor Nelsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Catherine J. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Charles Newton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 500,000 | 500,000 | - | - | Option (right to buy) | |
| Elizabeth Homans | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 1,479,500 | 1,479,500 | - | - | Option (right to buy) | |
| Stephen Hill | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 700,000 | 700,000 | - | - | Option (right to buy) |